US 8618270
Oligonucleotide analog and method for treating flavivirus infections
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8618270 (Oligonucleotide analog and method for treating flavivirus infections) held by Sarepta Therapeutics, Inc. expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00